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Abstract 
The purpose of this paper is to perform an
evidence based review for treatment of uni-
cameral  bone  cysts.  A  search  of  MEDLINE
(1966 to 2009) was conducted and the studies
were classified according to levels of evidence.
This review includes only comparative Level I-
III studies. The systematic review identified 16
studies. There is one level I study, one level II
study and the remaining 14 studies are level
III. Seven of the sixteen studies had statistical-
ly different results: three studies indicated that
steroid injection was superior to bone marrow
injection or curettage and bone grafting; one
study indicated that cannulated screws were
superior to steroid injections; one study indi-
cated resection and myoplasty was superior to
steroid injection; one study indicated a combi-
nation of steroid, demineralized bone matrix
and bone marrow aspirate, and curettage and
bone grafting were superior to steroid injec-
tion; and one study indicated that curettage
and bone grafting was superior to non-opera-
tive  immobilization.  Based  on  one  Level  I
study, including a limited number of individu-
als, steroid injection seems to be superior to
bone marrow injection. As steroid injections
have  already  demonstrated  superiority  over
bone marrow injections in a randomized clini-
cal trial, the next step would be a prospective
trial comparing steroid injections with other
treatments.
Introduction
Simple,  or  unicameral,  bone  cysts  are  a
benign lesion in growing children. While the
two  terms  are  used  interchangeably  some
would argue that bone cysts are not “simple”,
whereas the cysts are not always unicameral.
Cysts are more common in males (70%) and
typically  present  in  the  proximal  humerus
(70%) or femur (25%). While exact figures are
unknown, it is estimated that approximately
75% of children present with pathological frac-
ture.
1 Cysts heal in less than 15% of children
following fracture.
2 Although unicameral bone
cysts  are  believed  to  resolve  with  skeletal
maturity, without treatment these children are
at risk for pain, or recurrent fracture leading to
activity restriction for many years. 
Unicameral  bone  cysts  may  also  lead  to
growth disturbance. Growth arrest, a relatively
uncommon complication, may occur through
many  mechanisms.  The  disruptive,  hydrody-
namic assault of cyst fluid on the physis may in
itself  result  in  growth  disturbances.
3 Other
rare causes for growth arrest include multiple
fractures  through  the  cyst  that  damage  the
physis, direct extension of the cyst through the
physis, or as a result of treatment of cysts adja-
cent to the physeal plate.
4-6 Regardless of the
cause, growth retardation in the affected limb
may  lead  to  angular  deformity  and/or  limb
length discrepancy.
6
Recurrent pathological fractures in children
with unicameral bone cysts require immobi-
lization, and/or internal fixation, and restric-
tion of activities. Recurrent fractures, particu-
larly in the lower limb, may also cause limb
length discrepancy and deformity. In addition,
children are often afraid of their usual play
activities  or  are  restricted  from  all  sporting
activities by their parents or physician because
of  the  concern  of  fracture(s).  Finally,  some
children with unhealed cysts complain of pain.
7
Although the origin of this pain is unclear, the
pain seems to resolve with the healing of the
cyst.
8 Thus despite the benign nature of these
lesions, unicameral bone cyst can have signif-
icant detrimental effects on otherwise normal
children and their families.
Many  theories  have  been  proposed  to
explain the pathogenesis of unicameral bone
cysts. An early theory was that injury to the
growth plate leads to abnormal endochondral
bone formation.
9 Interest has also been drawn
to  the  cyst  lining  and  the  presence  of  bone
resorptive factors in the cyst fluid, including
interleukin 1-B and prostaglandin E2
10and oxy-
gen  free  radicals  and  lysosomes.
11,2 Another
theory suggests that vascular obstruction caus-
es cyst fluid to accumulate under pressure and
expand at the expense of the normal bone.
3,10-11
However, the uncertainty of the etiology has
led to a wide variety of treatments. 
Treatment  strategies  for  unicameral  bone
cysts include injection, mechanical disruption
of the cyst lining and/or wall, structural sup-
port,  decompression,  or  mixed  methods.
Injections  can  include  steroids,
13 bone  mar-
row,
14 demineralized  bone  matrix,
15 calcium
sulfate  pellets,
16 and  fibrin  sealant.
17
Mechanical disruption of the cyst lining or wall
is done by curettage. Structural support can be
done  with  flexible  intramedullary  nailing.
18
Decompression can be done with multiple drill
holes,
12 cannulated  screws,
19 and  different
types of nails.
20 Many mixed methods approach
the  cyst  on  multiple  levels  such  as  percuta-
neous  removal  of  cyst  lining,  curettage  to
break  up  septations,  intramedullary  decom-
pression, and injection of calcium sulfate pel-
lets.
16 To date, few comparative studies have
been conducted (Table 1). The purpose of this
study was to perform an evidence based review
of treatment of unicameral bone cysts.
Materials and Methods 
A search of MEDLINE (1966 to 2009) was
conducted using the following search string:
Bone cysts/ and (unicameral or multi-cameral
or simple). The search was limited to English
language, humans and children aged 0 to 18
years. The studies had the following inclusion
criteria: sample size greater than one; random-
ized controlled trial or comparative study; cysts
located in long bones; and all forms of treat-
ment including observation or fracture immo-
bilization. Studies were excluded if the cysts
were located in areas other than long bones,
i.e.  calcaneus  or  pelvis.  Studies  with  mixed
populations of cyst location were included, but
studies focusing exclusively on calcaneal cysts
were excluded. Studies of mixed populations
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Review
Table 1. Summary of Levels of Evidence I -III [N=1340].
Author Level Study Age of Follow-Up Definition Intervention Complications Outcome
Year of design population  years of
evidence years healed
Wright  I RCT Mean:  9.5 Mean: 2.2 Modified Neer /  Steroid injection  Fractures: 11 Steroid superior
et al. 2007
7 Range: 2.8 to 17.1 Range: 1.5 to 3.3 Cole classification [n=38] Complications: 0 to bone marrow
4 grade scale, healing  Autologous bone Fractures: 9 (P=0.01)
defined as grades 3 or 4: marrow injection [n=39] Complications: 2 
3) sclerosis around or within  superficial infections
a partially visible cyst;
4) complete healing with 
obliteration of cyst
Brecelj  II Prospective Mean: 9.8 Mean: 5.8 Chang classification Steroid injection  Fractures: none reported Cannulated screw
et al.2007
19 comparative Range: 2.7 to 16 Range: 1 to 13.1 4 grade scale, healing defined  [n=33] Complications: none reported superior to
as grades 1 or 2: Curettage + bone  Fractures: none reported steroid
1) Healed: cyst filled by formation  grafting [n=8] Complications: none reported (P=0.001)
of new bone with or without small  Cannulated screw  Fractures: complications: 
static radiolucent area(s) less than  [n=28] 3 broken
1 cm in size; screws (left in place)
2) Healing with defect: static radiolucent 
area(s), less than 50% of the diameter of 
the bone with adequate cortical 
thickness  to resist fracture.
Sung  III Retrospective  Mean: 11.2 Mean: 4.7 Outcome defined as: Steroid injection Fractures: 17 SDB superior
et al. 2008
21 comparative Range:  Range: 0.08 to 27 Treatment failure (defined clinically as [n=94] Complications: 5 deformity/  to steroid injection
not provided subsequent pathological fracture or need  growth disturbance (P<0.001)
for retreatment to prevent pathological  Curettage and bone Fractures: 1 Curettage and bone
fracture) or complications. grafting [n=39] Complications: grafting superior 
3 deformity/ growth disturbance to steroid (P=0.01)
SDB: Combination injection Fractures: 4 No difference
of steroid, demineralized  Complications:  between curettage
bone matrix, and bone  1 deformity/ growth disturbance  and SDB (P=0.23)
marrow aspirate
[n=34]
Cho  III Retrospective Mean: 11.2  Mean: 4.7  Modified Neer classification Steroid  injection [n=30] Fractures: 0 No difference
et al. 2007
22 comparative Range: 2 to 18 Range: 2 to 15.5 4 grade scale, healing defined as 1 or 2: Autologous bone marrow Complications: none reported between treatment 
1) Healed: cyst filled by new bone, with injection [n=28]  Fractures: 3 groups (P>0.05)
or without small radiolucent area(s)  Complications: none reported
<1 cm in size;
2) Healed with defects: radiolucent 
area(s)<50% of the diameter of bone, 
with enough cortical thickness 
to prevent fracture.
Chuo  III Retrospective Mean: 11.9 Mean 5.7  Modified Neer / Capanna classification Observation [n=6] Fractures: 0 No difference 
et al. 2003
23 comparative Range: 6 to 21 Range 2 to 12 4 grade scale, healing not defined  Complications:  between treatment
beyond grades. 1 malunion (humerus) groups (P=0.42)
1) Completely healed Curettage + bone grafting + Fractures: 0
2) Healed with residue ORIF [n=4] Complications: none reported
3) Recurred Cannulated screw [n=7] Fractures: 0
4) No response Complications: none reported
Chang  III Retrospective Mean: 9.1 Mean: 3.7  Modified Neer classification Steroid injection [n=65] Fractures: 26 No difference
et al. 2002
24 comparative Range:  Range: 1 to 9 4 grade scale, healing defined as 1 or 2: Complications: none reported between groups
Not provided 1) Healed: cyst filled by formation of new  Autologous bone marrow Fractures: none reported (P>0.05)
bone with or without small static,  injection [n=14] Complications: none reported
radiolucent area(s) less than 1 cm in size;
2) Healed with defect: static, radiolucent 
area(s) greater than 50% of the diameter 
of bone with enough cortical thickness
to prevent fracture.
Tsuchiya III Retrospective Mean: 15.2 Mean: 6.8 Not defined Curettage, multiple drilling Fractures: 2 No difference
et al. 2002
25 comparative Range: 8 to 22 Range: 0.7 to 12.3 + titanium cannulated screws  Complications: none reported between treatment
[n=15]  groups (P=0.12)
Curettage, multiple Fractures: 0
drilling + cannulated  Complications: none reported
hydroxyapatite pin [n=11]
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Table 1. Continued from previous page.
Author Level Study Age of Follow-Up Definition Intervention Complications Outcome
Year of design population  years of
evidence years healed
Bensahel  III Retrospective Mean: 7  Mean: 9  Not defined Steroid injection [n=55] Fractures: 0 Resection and
et al. 1998
26 comparative Range: 2 to14 Range: 3 to 15 Complications: 0 myoplasty superior to
Resection + myoplasty [n=50] Fractures: 0 steroid injection
Complications: 0 (P=0.02)
Gennari  III Retrospective Mean: 7  Mean: 6 Not defined Steroid injection [n=3] Fractures: 0 No difference
et al. 1995
27 comparative Range: 3 to 13 Range:  Complications: 0 between treatment
Not provided Curettage + bone grafting  Fractures: 2 groups (P=0.08)
+  ostesynthesis [n=10] Complications: 2 limb shortenings
Rupture of cyst w/o  Fractures: 2
osteosynthesis [n=5] Complications: 3 limb shortenings
Orthopedic treatment [n=2] Fractures: 0
Complications: 1 limb lengthening
Mylle  III Retrospective Mean: 15  Mean: 8.5 Neer/Campanacci Classification Steroid injection [n=20] Fractures: 0 Steroid injection
et al. 1992
28 comparative Range:  Range:  4 grade scale, healed defined as 2 or 3: Complications:  superior to
Not provided Not provided 2) Incomplete healing: new bone  1 superficial infection curettage +
formation fills the area previously  Curettage +/- bone grafting  Fractures: 0 bone grafting
occupied by the cyst. Small sites of [n=21] Complications:  (P=0.03)
osteolysis remain visible in the 3 superficial infection
boundaries of the cyst; Curettage + steroid  Fractures: 0
3) Complete healing: the space   injection [n=6] Complications: 
occupied by the SBC is completely filled  1 superficial infection
by new  bone or by hydroxyapatite. No treatment [n=12] Fractures: 10
Complications: 
1 growth disturbance
Farber III Retrospective Mean: 8.1 Mean: 6.7 Not defined Steroid injection [n=17] Fractures: none reported No difference
et al. 1990
29 comparative Range:  Range:  Complications: 0 between
Not provided Not provided Curettage  Fractures: none reported treatment groups
+ bone grafting [n=19] Complications: 0 (P=0.27) 
Bovill   III Retrospective Mean: 8.9 Mean: 5.6 Oppenheim and Galleno  Steroid injection [n=12] Fractures: 3 No difference between
et al. 1989
30 comparative Range: 0.75 to 30 Range:   Modification Complications: 0 treatment groups
Not provided 4 grade scale, healing defined as 1 or 2: Surgical treatment (multiple)  Fractures: 1 (P=0.11)
1) Resolution: 70-100% obliteration and  [n=15] Complications: 
renewed cortical thickening on serial X-ray; 3 limb deformity, 1 infection, 
2) Incomplete resolution: 50-70%  1 median nerve palsy, 
obliteration with renewed cortical thickening. and 1 keloid.
Non-surgical treatment  Fractures: 0
(orthopedic) [n=5] Complications: 0
Pentimalli  III Retrospective Mean: 9.1 Mean: 7 3 grade scale: Steroid injection [n=20] Fractures: none reported No difference  between
et al.1987
31 comparative Range: 4-15 Range: (3 to 20) healing not defined further Complications: none reported treatment
1) Good: cyst had completely disappeared,  Curettage +  Fractures: none reported groups (P=0.29)
the thickness of cortical bone was normal,  bone grafting [n=20] Complications: none reported
and no irregularity was present in the 
medullary canal;
2) Fair: cyst had disappeared, but the 
cortical bone was thinner than normal
and some irregularities were evident 
inside the medullary canal;
3) Poor: cyst was still present, although 
reduced in volume, and/or there was 
shortening of the affected bone by more 
than 2 cm, with the bone slightly deformed 
at the site of the cyst.
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including children and adults were included as
long  as  the  mean  age  of  patients  ranged
between 0 and 18 years. 
The  following  information  was  collected
from each of the studies: year of publication,
study design, age of patients, duration of fol-
low-up, definition/grading system for cyst heal-
ing, treatment(s), sample size, and outcome.
The studies were classified according to levels
of evidence as described in the Journal of Bone
and Joint Surgery, where therapeutic studies
are classified into five levels based on study
design.
34 This review includes levels I-III only.
35
Level I evidence consists of high quality ran-
domized  controlled  trials  and  systematic
reviews  of  level  I  studies  with  consistent
results. Level II evidence includes lesser quali-
ty  randomized  controlled  trials,  prospective
comparative studies, and systematic reviews of
level II studies or level I studies with inconsis-
tent results. Level III evidence consists of case-
control studies, retrospective comparative stud-
ies, and systematic review of level III studies.
34
P values were obtained in two ways. First, if
statistical analysis was performed in the origi-
nal study then the associated P value was used.
Second, if a P value was not provided but sta-
tistical data (absolute or relative) on cyst heal-
ing was available, then a c
2 test was used to
calculate a P value. Cyst “healing” was defined
as “complete healing or partial healing (with
small residual cyst)” when a cyst graded scale
was specified. When cyst healing index was
not  specified,  the  author’s  description  of
“healed” was used.
Results
The  literature  search  yielded  263  articles
(Figure 1). Of these, 247 were excluded for the
following reasons: 99 were levels IV or V (case
series,  editorial,  or  review  article);  53  were
focused  on  non-long  bones  (calcaneal,
mandible,  pelvis);  36  were  not  therapeutic
(diagnostic or prognostic); 28 were differential
diagnosis  (benign  lesions  or  malignant
tumors); 18 focused on treatment of complica-
tions  (pathological  fractures,  growth  arrest,
limb  length  discrepancy);  and  13  had  an
English abstract but the paper was written in
another  language.  This  review  included  the
results  of  16  identified  studies  as  listed  in
Table 1. Years of publication span 1966 to 2009
and include a total number of 1,340 patients
and 13 different types of treatment. Table 2
provides ranges of treatment success. There is
one level I study, one level II study and the
remaining 14 studies are level III. Studies are
presented  chronologically  by  level,  starting
with the most current publications.
Level I studies
In the one level I study, Wright et al.
7 report-
ed  a  randomized  clinical  trial  comparing
intralesional bone marrow [n=39] and methyl-
prednisolone  [n=38]  injections.  This  trial
involved  24  centers  and  47  surgeons  across
North America and India with follow-up of 2.2
years. Results of the trial indicated that steroid
injection (42% healed) was significantly better
than bone marrow (23% healed) for healing
Review
Table 1. Continued from previous page.
Author Level Study Age of Follow-Up Definition Intervention Complications Outcome
Year of design population  years of
evidence years healed
Campanacci  III RetrospectiveThe majority  C + BG Modified Neer classification Steroid injection [n=141] Fractures: 13 Steroid injection
et al.1986
32 comparative of these cases  Mean:  4 grade scale, healing not defined further:  Complications: superior to curettage
were under not provided 1) Complete healing – the space occupied 28 limb length discrepancies, and bone grafting
the age of  Range: 1-35 by cyst was completely filled by new  1 avascular necrosis (P=<0.001)
15 years. SI bone formation; Curettage Fractures: none reported
Mean:  2) Incomplete healing – new bone + bone grafting [n=178] Complications: 25 limb 
Not provided formation did fill the area previously length discrepancies
Range: 1-8 occupied by the cyst; small sites of osteolysis
were seen within the boundaries of the cyst;
3) Recurrence – initially the cyst was 
consolidated with new bone, and areas of 
osteolysis with definite cortical 
thinning appeared;
4) No response – no clinical or radiographic 
evidence of amelioration was noted. 
Oppenheim  III RetrospectiveMean: 74%  Mean: 3.8  4 grade scale, healed defined as 1 or 2: Steroid injection [n=20] Fractures: none reported No difference between
et al. 1984
33 comparative of cases  Range:  0.5 to 12 1) Healed: complete obliteration Complications: 1 mild steroid treatment groups
presenting of the cyst, or at most a 1 cm  flush, 1 shortening of humerus (P=0.22)
between the  non progressive radiolucent Curettage or excision + Fractures: none reported
ages of 5 and  area and a serial increase grafting [n=37] Complications: 6, including 
15 years. in cortical bone thickness; coxa vara, wound infection, 
Range: 1.5 to 26 2) Improved: Non progressive,  physeal arrest and 
radiolucent areas 1-3 cm in diameter extremity shortening
and enough cortical thickness 
to prevent fractures.
Neer et al. III RetrospectiveMean: 12.02 Mean: not provided 3 grade scale Curettage  Fractures: 3 femoral Curettage + bone
1946 comparative Range: 1.5 to 54 Range:  1) excellent: complete + bone grafting [n=125] Complications: grafting superior
non- operative  obliteration of the cyst 1 wound infection, to non operative
1 to 10 during the period of observation; 4 premature  immobilization
2) Residual defect: one or more static,  epiphyseal closures (P<0.001)
cyst-like residua with good bone  Non-operative  Fractures: 32 humeral, 4 femoral
strength by the appearance  immobilization after  Complications: 4 growth 
of roentgenogram; fracture [n=45] disturbance/ deformity
3) Re-operation: subsequent operation 
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bone cysts (P=0.01). The authors also found
that  both  subsequent  fracture  (P=0.04)  and
increased cyst area (P=0.03) were significant-
ly  associated  with  non-healing  of  the  cyst.
Complications included 9 subsequent fractures
and 2infections in the bone marrow injection
group, and 11 fractures and no infections in
the steroid group (P=0.12).
Level II studies
In the one level II study, Brecelj et al.
19 com-
pared steroid injection (n=33), curettage and
bone grafting (n=8), and a specially designed
cannulated  screw  (n=28)  in  a  prospective
comparative study with a follow-up of 5.8 years.
All three groups required multiple courses of
treatment. The cannulated screw group, after
two attempts, demonstrated the highest rate of
healing  (P=0.001)  at  65%  compared  to  50%
and 19% for open curettage and methylpred-
nisolone  injections,  respectively.  Complica-
tions included three screws that broke during
removal and were left in place. None of the fol-
lowing factors were related to treatment suc-
cess: sex, cyst size ratio, cyst activity, age at
first treatment, pathological fractures or num-
ber of humeral cysts (with exception of second
steroid injection, there were a higher number
of humeral cysts in the failed treatment group
[P=0.017]).
Level III studies
The remaining 14 studies were level III. A
retrospective study by Sung et al.
21 compared
steroid  (n=94),  curettage  and  bone  grafting
(n=39), and a combination injection (SDB) of
steroid, demineralized bone matrix, and bone
marrow  aspirate.  Results  indicate  that  both
curettage and bone grafting and the combina-
tion injection (SBD) were superior to steroid,
P=0.01  and  P<0.001  respectively.  However,
there was no difference between curettage and
bone grafting and the combination injection
(SBD)  (P=0.23).  Subsequent  pathological
fractures  were  reported  in  18%  (17/94)  of
patients  treated  with  steroid  injection,  2.6%
(1/39) of patients treated with curettage, and
12% (4/34) of patients treated with the combi-
nation  injection  SDB.  Other  complications,
such as deformity or growth disturbance, were
reported in 5.3% (5/94) of patients treated with
steroid injection, 7.7% (3/39) of patients treat-
ed with curettage and 2.9% (1/34) of patients
treated with SDB.
A  retrospective  study  by  Cho  et  al.
22 com-
pared bone marrow (n=28) and steroid (n=30)
injections with a follow-up of 4.7 years. The
overall  success  rates  were  86.7%  after  2.5
injections in the steroid group and 92.0% after
1.8  injections  in  the  bone  marrow  group
(P>0.05).  Despite  this  lack  of  difference
between  treatment  groups  in  the  final  out-
come, they found that the steroid group had a
higher  recurrence  rate  after  one  injection
(P<0.05) and needed more injections to com-
plete  healing  (P<0.05).  Cho  et  al. indicated
there  was  no  association  between  healing
after  the  initial  procedure  and  age,  gender,
location of the cyst, cyst activity or previous
pathological fracture in either the bone mar-
row or steroid group (P>0.05). Complications
included  three  fractures  after  bone  marrow
injections in patients who did not follow post-
operative immobilization instructions.
A retrospective study by Chuo et al.
23 com-
pared cannulated screws (n=7), curettage and
bone grafting with ORIF (n=4), and observa-
tion  (n=6)  with  a  follow-up  of  5.7  years.
Although  the  authors  concluded  cannulated
screws were preferred, the difference in rates
of healing between treatment groups (P=0.42)
was not statistically different. There was one
complication of a malunion in the observation
group. 
A retrospective study by Chang et al.
24 com-
pared steroid (n=65) and bone marrow injec-
tions  (n=14)  with  a  follow-up  of  3.7  years.
Although  there  was  no  statistical  difference
between treatment groups (P>0.05), the rate
of healing after 2 injections in the bone mar-
row  group  and  1.5  injections  in  the  steroid
group was 37% and 56%, respectively. No com-
plications were reported in either group. Cysts
that healed after one injection (of either bone
marrow or steroid) compared with those that
didn’t heal, had a significant difference in the
Review
Table 2. Rates of success by treatment.
Treatment: N=1340 [n] Range of success (%)
Steroid injection [563] 15-100
7,19,21,22,24,26-33
Bone marrow injection [81] 23-92
22,24
Curettage and bone grafting [447] 36-85 
2,7, 19,21,28,29,31-33
Cannulated screw [35] 46-100
19,23
Steroid injection + DBM + bone marrow aspirate[34] 29-5
021
Curettage + bone grafting + ORIF [4] 75
23
Curettage + multiple drilling + titanium cannulated screw [15] 80
25
Curettage + multiple drilling + hydroxyapatite pin [11] 100
25
Resection + myoplasty [50] 72
26
Curettage + bone grafting + osteosynthesis  [10] 100
27
Cyst rupture + osteosynthesis [5] 60
27
Orthopedic treatment [70] 4-100
2,27,30
Mixed surgical treatment [15] 87
30
Figure  1.  Literature
search  and  review
results.[Orthopedic Reviews 2010; 2:e13] [page 45]
size of the cyst (P<0.01). Sex, cyst activity, pre-
vious pathological fracture, and site of the cyst
had no affect on healing.
In  2002,  Tsuchiya  et  al.
25 retrospectively
compared curettage, multiple drilling and tita-
nium  cannulated  screws  (n=15)  and  curet-
tage, multiple drilling and cannulated hydrox-
yapatite pins (n=11) with a follow-up of 6.8
years. The authors recommended the hydrox-
yapatite pins because the pins didn’t require
removal. Although all patients receiving can-
nulated titanium screws healed, there was no
difference  in  healing  between  treatment
groups  (P=0.12).  There  were  two  complica-
tions in the cannulated screw group (one frac-
ture and one fissure fracture) and no compli-
cations in the hydroxyapatite pin group.
Bensahel  et  al.
26 retrospectively  compared
resection and myoplasty using a local muscle
flap (n=50) and steroid injections (n=55) with
a  follow-up  of  nine  years.  Resection  and
myoplasty compared with steroids had a high-
er rate of healing of 71% and 50%, respectively
(P=0.02). There were no complications report-
ed in either group. 
Gennari  et  al.
27 retrospectively  compared
steroid  injection  (n=3),  curettage  and  bone
grafting and osteosynthesis (n=10), rupture of
cyst without osteosynthesis (n=5), and obser-
vation (or “orthopedic treatment”) (n=2) in
cysts in the upper third of the femur with a fol-
low-up of six  years. There was no difference in
rates  of  healing  between  treatment  groups
(P=0.08).  There  were  two  limb  shortenings
(<2 cm) in the curettage group, three shorten-
ings (≥2 cm) in the cyst rupture group, and
one lengthening (>2 cm) in the observation
group.
Mylle  et  al.
28 retrospectively  compared
steroid injection (n=20), curettage and bone
grafting (n=21), curettage and steroid injec-
tion (n=6), and no treatment (n=12) with a
follow-up  of  8.5  years.  Steroid  injection  was
found  to  be  superior  to  curettage  and  bone
grafting (P=0.03) with 90% and 43% healing,
respectively.  Complications  included  one
superficial infection in the steroid group, three
in the curettage and bone grafting group, and
one  in  the  curettage  and  steroid  injection
group.  There  were  ten  subsequent  fractures
and one growth disturbance in the ‘no treat-
ment’ group. 
Farber  et  al.
29 retrospectively  compared
steroid  injections  (n=17)  and  curettage  and
bone grafting (n=19) with a follow-up of 6.7
years. Although methylprednisolone has high-
er rates of healing of 70% compared with 53%
in the curettage group, the difference was not
statistically different (P=0.27). No complica-
tions were reported. 
Bovill  et  al.
30 retrospectively  compared
steroid  injections  (n=12),  multiple  surgical
techniques  (n=15),  and  observation  (n=5)
with a follow-up of 5.6 years. No difference was
found between rates of healing in the treat-
ment groups (P=0.11). There were eight com-
plications  in  the  surgical  group:  three  leg
length  deformities,  one  infection,  one  tran-
sient median nerve palsy, one subsequent frac-
ture, and one keloid. There were three subse-
quent fractures in the steroid group.
Pentimalli et al.
31 retrospectively compared
steroid  injections  (n=20)  and  curettage  and
bone grafting (n=20) with a follow-up of seven
years.  Although  the  authors  recommend
steroid  injections  because  the  radiographic
results  were  better  with  a  lower  recurrence
rate, the rates of healing for steroid injections
(95%) and curettage and bone grafting (85%)




steroid injections (n=141) and curettage and
bone grafting (n=178) with a follow-up of one
to 35 years (mean not provided). Although the
authors indicated the end results were compa-
rable  in  both  groups,  the  steroid  group  had
higher rates of healing than curettage on bone
grafting (P<0.0001), 91% and 68%, respective-
ly. The steroid group had 28 limb length dis-
crepancies, 13 subsequent fractures, and one
avascular  necrosis.  The  curettage  and  bone




steroid  injections  (n=20)  and  curettage  or
excision with or without grafting (n=37) with
a follow-up of 3.8 years. There was no differ-
ence in rates of healing between steroid injec-
tion  (40%)  and  the  curettage  group  (57%)
(P=0.22), although the authors recommended
the steroid injection due to its simplicity and
reduced morbidity. Complications included one
mild steroid flush (2.4 g dose of Depo Medrol
was inadvertently given) and one shortening
of  the  humerus  in  the  steroid  group.  There
were 6 complications in the curettage group
which  included  coxa  vara,  wound  infection,
physeal arrest, and extremity shortening.  
Neer et al.
2 retrospectively compared curet-
tage and bone grafting (n=125) with immobi-
lization after fracture (n=45) with a minimum
2-year follow-up. Curettage and bone grafting
had higher rates of healing than the non-oper-
ative  treatment  (P<0.001),  77%  and  4%,
respectively. Complications for the non-opera-
tive group included subsequent fractures in 36
patients and 4 growth disturbances and defor-
mity.  Complications  for  the  curettage  group
were 3 subsequent fractures, one wound infec-
tion,  and  4  premature  epiphyseal  closures
which led to shortening of 1-3 cms. 
Discussion
Seven of the sixteen studies had statistical-
ly different results: three studies indicated that
steroid injection was superior to bone marrow
injection or curettage and bone grafting;
7,28,32
one  study  indicated  that  cannulated  screws
were superior to steroid injections;
19 one study
indicated resection and myoplasty was superi-
or to steroid injection;
30 one study indicated a
combination  of  steroid,  demineralized  bone
matrix and bone marrow aspirate, and curet-
tage and bone grafting were superior to steroid
injection;
21 and one study indicated that curet-
tage and bone grafting was superior to non-
operative immobilization.
2 In interpreting the
literature the different treatments have differ-
ent pros and cons. The treatments range from
simple injections to open treatments to inter-
nal  fixation.  The  invasiveness  must  be  con-
trasted  with  the  need  for  repeat  treatment
such as steroids which may require multiple
injections. These factors must all be balanced
against risk of fracture and probability of suc-
cess.
The  literature  has  several  shortcomings.
First,  the  outcome  for  almost  all  studies
(15/16)  was  based  on  radiographic  healing
rather than patient based outcomes such as
fracture, pain or function. Second, there was
variability in the type of radiographic healing
scale or index used. Eight of the sixteer stud-
ies used a modification of the Neer criteria,
four did not define the scale or index used, and
four  used  their  own  original  criteria.  Third,
there was a wide variation in treatment proto-
cols. For example, although all steroid injec-
tion  protocols  used  methylprednisolone
acetate, the dosage ranged from 40 to 250 mg
and number of injections ranged from one to 6.
Bone  marrow  injection  protocols  also  varied
including amount withdrawn from each har-
vest site (2-8 mL), amount injected into cyst
(9-50  ml),  and  number  of  injections  (1-4).
Fourth, there was different duration of follow-
up with the mean ranging from 2.2 to 9.0 years
and overall range from one to 35 years. Finally,
the studies had a variety of sample sizes, rang-
ing from very small (n=2) to 178. 
As unicameral bone cysts and corresponding
pathological  fractures  present  in  different
locations, variations in treatment may result.
Pathological  fractures  in  the  lower  extremi-
ties, particularly in the proximal femur, have
greater  potential  for  complications.
Fracture(s) in this area may result in physeal
damage,  coxa  vara,  extremity  shortening  or
avascular necrosis.
27,36 As cysts rarely heal fol-
lowing fracture,
36,37 risk of refracture leads to
restriction of physical activities. As failure to
achieve radiographic healing within the first
year following presentation increases the risk
of refracture,
38 the goal of treatment is to stabi-
lize the fracture and treat the cyst simultane-
ously. Flexible intramedullary nails have been
promoted  as  they  stabilize  the  fracture  (or
pending  pathological  fracture)  and  provide
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treatment  of  the  cyst  through  continuous
decompression.
39-45 Advantages  of  this  treat-
ment include stability to the bone and early
mobilization  of  the  patient.  Complications
include nail revisions due to bone growth and
difficulty of anchoring nails due to lack of bone
in the femoral neck.
41
There are few reports in the literature on
prophylactic internal fixation of bone cysts at
risk for pathological fracture in the proximal
femur.
39,41,44,45 These reports are case series with
the majority of patients presenting with patho-
logical fractures. The authors acknowledge the
numbers for cysts treated prophylactically with
internal fixation are small but indicate they
see no difference in rates of cyst healing when
compared  to  cysts  treated  with  concurrent
pathological fracture.
Treatment  for  unicameral  bone  cysts  has
evolved  over  the  years.  Curettage  and  bone
grafting  was  used  for  many  years.
5
Unfortunately,  this  aggressive  approach  had
high recurrence rates of 40-50% with the asso-
ciated scar and morbidity of surgery.
32 A less
intrusive  technique,  intralesional  steroid
injections,
13 became  a  common  treatment
modality for many years with rates of healing
ranging from 41-90%.
8,13,27,32,33,46 In 1996, Lokiec
et al.
14 published a preliminary study on bone
marrow injections reporting that all ten cysts
demonstrated  radiographic  healing.
Subsequent  reported  rates  of  healing  using
bone  marrow  injections  ranged  from  42-
100%.
14,22,24,47-49Based on early promising results,
many surgeons shifted from steroid injection
to bone marrow. Based on the levels of evi-
dence analysis, this may have been a prema-
ture shift in clinical practice.
In conclusion, based on one level I study,
including  a  limited  number  of  individuals,
steroid injection seems to be superior to bone
marrow injection. As steroid injections have
already  demonstrated  superiority  over  bone
marrow  injections  in  a  randomized  clinical
trial, the next step would be a prospective trial
comparing  steroid  injections  to  other  treat-
ments.
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